Farringdon Capital »

Regeneron Pharmaceuticals shares owned by Farringdon Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Farringdon Capital from 13F filings

Historical chart of Farringdon Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Farringdon Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Farringdon Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $597k 1.1k 562.27
2025-03-31 $258k 407 634.23

More positions owned by Farringdon Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Short Treas Bd (SHV)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
S&p Global (SPGI)
Haleon Spon Ads (HLN)
Rentokil Initial Sponsored Adr (RTO)
Broadcom (AVGO)
Vaneck Bitcoin Etf Sh Ben Int (HODL)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Bitwise Bitcoin Etf Tr Shs Ben Int (BITB)
Invesco Galaxy Bitcoin Etf Com Shs Ben Int (BTCO)
Ishares Ethereum Tr SHS (ETHA)
Grayscale Ethereum Mini Tr E Shs New (ETH)
Sprott Asset Management Physical Gold Tr (PHYS)
Capital One Financial (COF)

View all positions for Farringdon Capital

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals